National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to alert potential applicants to a change in the expiration date for Funding Opportunity Announcement (FOA) PAR-18-643 "NHLBI Clinical Ancillary Studies (R01 Clinical Trial Optional)". This FOA will expire on January 24, 2020 (earlier than previously published). This will negate the following Application Due Date(s): April 30, 2020, August 24, 2020, and December 18, 2020.

Potential applicants are advised to regularly check the NIH Guide and/or the NHLBI web page for related funding opportunity announcements.

No other changes are being made to this FOA.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Division of Cardiovascular Sciences
Jue Chen, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0550
Email: [email protected]

Division of Lung Diseases
Aaron Laposky, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0199
Email: [email protected]

Division of Blood Diseases and Resources
Sharon Smith, Ph.D.
National Heart, Lung, and Blood Institute
Telephone: 301-435-0065
Email: [email protected]